246 related articles for article (PubMed ID: 18005198)
1. Measurement of factors influencing the participation of patients with prostate cancer in clinical trials: a Canadian perspective.
Davison BJ; So A; Goldenberg SL; Berkowitz J; Gleave ME
BJU Int; 2008 Apr; 101(8):982-7. PubMed ID: 18005198
[TBL] [Abstract][Full Text] [Related]
2. Why cancer patients enter randomized clinical trials: exploring the factors that influence their decision.
Wright JR; Whelan TJ; Schiff S; Dubois S; Crooks D; Haines PT; DeRosa D; Roberts RS; Gafni A; Pritchard K; Levine MN
J Clin Oncol; 2004 Nov; 22(21):4312-8. PubMed ID: 15514372
[TBL] [Abstract][Full Text] [Related]
3. Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret.
Stryker JE; Wray RJ; Emmons KM; Winer E; Demetri G
Patient Educ Couns; 2006 Oct; 63(1-2):104-9. PubMed ID: 16242898
[TBL] [Abstract][Full Text] [Related]
4. Factors determining participation in prevention trials among systemic lupus erythematosus patients: a qualitative study.
Costenbader KH; Brome D; Blanch D; Gall V; Karlson E; Liang MH
Arthritis Rheum; 2007 Feb; 57(1):49-55. PubMed ID: 17266094
[TBL] [Abstract][Full Text] [Related]
5. Men considering a hypothetical treatment for prostate cancer: a comparison to patients.
Van Manen L; Feldman-Stewart D; Brundage MD
Patient Educ Couns; 2006 Apr; 61(1):33-42. PubMed ID: 16257170
[TBL] [Abstract][Full Text] [Related]
6. Osteoporosis risk and interest in strength training in men receiving androgen ablation therapy for locally advanced prostate cancer.
Ott C; Fulton MK
J Am Acad Nurse Pract; 2005 Mar; 17(3):113-22. PubMed ID: 15748224
[TBL] [Abstract][Full Text] [Related]
7. Testing an alternate informed consent process.
Yates BC; Dodendorf D; Lane J; LaFramboise L; Pozehl B; Duncan K; Knodel K
Nurs Res; 2009; 58(2):135-9. PubMed ID: 19289935
[TBL] [Abstract][Full Text] [Related]
8. The information needed by Canadian early-stage prostate cancer patients for decision-making: stable over a decade.
Feldman-Stewart D; Brennenstuhl S; Brundage MD
Patient Educ Couns; 2008 Dec; 73(3):437-42. PubMed ID: 18762405
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.
Davison BJ; Oliffe JL; Pickles T; Mroz L
Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342
[TBL] [Abstract][Full Text] [Related]
10. Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer.
Davison BJ; Goldenberg SL
BJU Int; 2011 Dec; 108(11):1787-93. PubMed ID: 21507187
[TBL] [Abstract][Full Text] [Related]
11. Factors that influence a patient's decision to participate in a phase I cancer clinical trial.
Schutta KM; Burnett CB
Oncol Nurs Forum; 2000 Oct; 27(9):1435-8. PubMed ID: 11058975
[TBL] [Abstract][Full Text] [Related]
12. Factors that influence the recruitment of patients to Phase III studies in oncology: the perspective of the clinical research associate.
Wright JR; Crooks D; Ellis PM; Mings D; Whelan TJ
Cancer; 2002 Oct; 95(7):1584-91. PubMed ID: 12237929
[TBL] [Abstract][Full Text] [Related]
13. Patient entry into randomized controlled trials of colorectal cancer treatment: factors influencing participation.
Solomon MJ; Pager CK; Young JM; Roberts R; Butow P
Surgery; 2003 Jun; 133(6):608-13. PubMed ID: 12796726
[TBL] [Abstract][Full Text] [Related]
14. Identifying motivations and barriers to patient participation in clinical trials.
Jones JM; Nyhof-Young J; Moric J; Friedman A; Wells W; Catton P
J Cancer Educ; 2006; 21(4):237-42. PubMed ID: 17542716
[TBL] [Abstract][Full Text] [Related]
15. Understanding the attitudes of the elderly towards enrolment into cancer clinical trials.
Townsley CA; Chan KK; Pond GR; Marquez C; Siu LL; Straus SE
BMC Cancer; 2006 Feb; 6():34. PubMed ID: 16466574
[TBL] [Abstract][Full Text] [Related]
16. Post-study aspirin intake and factors motivating participation in a colorectal cancer chemoprevention trial.
Sample DA; Sinicrope PS; Wargovich MJ; Sinicrope FA
Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):281-5. PubMed ID: 11895878
[TBL] [Abstract][Full Text] [Related]
17. Impact of providing audiotapes of primary treatment consultations to men with prostate cancer: a multi-site, randomized, controlled trial.
Hack TF; Pickles T; Bultz BD; Ruether JD; Degner LF
Psychooncology; 2007 Jun; 16(6):543-52. PubMed ID: 16991107
[TBL] [Abstract][Full Text] [Related]
18. Hypertensive patients' willingness to participate in placebo-controlled trials: implications for recruitment efficiency.
Halpern SD; Karlawish JH; Casarett D; Berlin JA; Townsend RR; Asch DA
Am Heart J; 2003 Dec; 146(6):985-92. PubMed ID: 14660989
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing Hispanic participation in prostate cancer screening.
Zimmerman SM
Oncol Nurs Forum; 1997 Apr; 24(3):499-504. PubMed ID: 9127362
[TBL] [Abstract][Full Text] [Related]
20. Decision-making and breast cancer clinical trials: how experience challenges attitudes.
Mancini J; Genève J; Dalenc F; Genre D; Monnier A; Kerbrat P; Largillier R; Serin D; Rios M; Roché H; Jimenez M; Tarpin C; ; Julian Reynier C
Contemp Clin Trials; 2007 Nov; 28(6):684-94. PubMed ID: 17434812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
